Company Profile
Journey Medical Corporation Stock Price, News & Catalysts
- Ticker:
- DERM
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
6.46 USD (-3.87%)
Close
Last updated: August 17, 2026
166M USD
Market cap
Why the stock is moving
As of Aug 17, 2026, DERM closed down 3.87% at $6.46. No new same-company headline was identified in the current news window.
Company overview
Prescription Dermatology Company
Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.
Emrosi
Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the company's presence in a large chronic dermatology market.
Established Portfolio
Journey Medical markets nine branded prescription drugs for common skin conditions. This portfolio allows the same commercial infrastructure to support multiple products and physician relationships.
Focused Commercial Model
The company emphasizes targeted product acquisition and specialist promotion rather than maintaining a broad internal discovery platform. Journey Medical was founded by Fortress Biotech but operates as a separately listed company.
Future catalysts
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Journey Medical Corporation (DERM)?
Journey Medical Corporation (DERM) most recently closed at 6.46 USD, a -3.87% move versus the previous session.
What is the market cap of Journey Medical Corporation (DERM)?
Journey Medical Corporation currently has a market capitalization of 166M USD on BioPharmSignal.
What does Journey Medical Corporation do?
Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization. Emrosi Emrosi is an oral treatment for inflammatory lesions of rosacea and is central to Journey Medical's current commercial expansion. The product broadens the...
On which exchange is DERM stock listed?
Journey Medical Corporation (DERM) is associated with NASDAQ, United States, Biopharma.
What is Prescription?
Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.
Which conditions is Journey Medical Corporation targeting with Prescription?
Journey Medical Corporation is associated with dermatology based on its company overview and current catalyst commentary.
What is Dermatology?
Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.
What is Journey?
Prescription Dermatology Company Journey Medical develops, acquires, and commercializes FDA-approved prescription products for dermatologic conditions through a specialist sales organization.